These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35114407)

  • 1. Plant expression systems as an economical alternative for the production of iELISA coating antigen AHSV VP7.
    Fearon SH; Dennis SJ; Hitzeroth II; Rybicki EP; Meyers AE
    N Biotechnol; 2022 May; 68():48-56. PubMed ID: 35114407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cell-mediated immune responses to plant-produced African horse sickness virus VP7 quasi-crystals.
    Fearon SH; Dennis SJ; Hitzeroth II; Rybicki EP; Meyers AE
    Virus Res; 2021 Mar; 294():198284. PubMed ID: 33421520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
    Maree S; Paweska JT
    J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Microsphere-based Immunoassay for Serological Detection of African Horse Sickness Virus and Comparison with Other Diagnostic Techniques.
    Sánchez-Matamoros A; Beck C; Kukielka D; Lecollinet S; Blaise-Boisseau S; Garnier A; Rueda P; Zientara S; Sánchez-Vizcaíno JM
    Transbound Emerg Dis; 2016 Dec; 63(6):e270-e277. PubMed ID: 25693720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.
    Rutkowska DA; Mokoena NB; Tsekoa TL; Dibakwane VS; O'Kennedy MM
    BMC Vet Res; 2019 Dec; 15(1):432. PubMed ID: 31796116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of monoclonal antibodies binding to the VP7 protein of African horse sickness virus.
    Luciani M; Armillotta G; Ciarelli A; Ulisse S; Teodori L; Bortone G; Giamboi A; Monaco F; Tittarelli M; Di Ventura M; Iannetti L; Podaliri Vulpiani M; Di Febo T
    J Virol Methods; 2019 Aug; 270():131-136. PubMed ID: 31095974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity of plant-produced African horse sickness virus serotype 5 chimaeric virus-like particles (VLPs) and viral protein 2 (VP2) vaccines in IFNAR
    O'Kennedy MM; Coetzee P; Koekemoer O; du Plessis L; Lourens CW; Kwezi L; du Preez I; Mamputha S; Mokoena NB; Rutkowska DA; Verschoor JA; Lemmer Y
    Vaccine; 2022 Aug; 40(35):5160-5169. PubMed ID: 35902279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the Role of African Horse Sickness Virus VP7 Protein Crystalline Particles on Virus Replication and Release.
    Bekker S; Potgieter CA; van Staden V; Theron J
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
    van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
    J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The seroprevalence of African horse sickness virus, and risk factors to exposure, in domestic dogs in Tshwane, South Africa.
    Hanekom J; Lubisi BA; Leisewitz A; Guthrie A; Fosgate GT
    Prev Vet Med; 2023 Apr; 213():105868. PubMed ID: 36739812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a Soluble African Horse Sickness Virus VP7 Protein Capable of Forming Core-like Particles.
    Bekker S; Huismans H; van Staden V
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1.
    Wang Y; Ong J; Ng OW; Songkasupa T; Koh EY; Wong JPS; Puangjinda K; Fernandez CJ; Huangfu T; Ng LC; Chang SF; Yap HH
    Emerg Infect Dis; 2022 Dec; 28(12):2446-2454. PubMed ID: 36417933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of a new lateral flow assay for simultaneous detection of antibodies against African Horse Sickness and Equine Infectious Anemia viruses.
    Costa S; Sastre P; Pérez T; Tapia I; Barrandeguy M; Sánchez-Vizcaíno JM; Sánchez-Matamoros A; Wigdorovitz A; Sanz A; Rueda P
    J Virol Methods; 2016 Nov; 237():127-131. PubMed ID: 27616197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of reverse transcriptase-polymerase chain reaction (RT-PCR) and dot-blot hybridisation for the detection and identification of African horse sickness virus nucleic acids.
    Zientara S; Sailleau C; Moulay S; Crucière C; el-Harrak M; Laegreid WW; Hamblin C
    Arch Virol Suppl; 1998; 14():317-27. PubMed ID: 9785517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
    van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
    Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of plant-produced African horse sickness virus-like particles: implications for a novel vaccine.
    Dennis SJ; Meyers AE; Guthrie AJ; Hitzeroth II; Rybicki EP
    Plant Biotechnol J; 2018 Feb; 16(2):442-450. PubMed ID: 28650085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness.
    van Rijn PA; Maris-Veldhuis MA; Boonstra J; van Gennip RGP
    Vaccine; 2018 Jun; 36(25):3584-3592. PubMed ID: 29759377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. African horse sickness outbreaks caused by multiple virus types in Ethiopia.
    Aklilu N; Batten C; Gelaye E; Jenberie S; Ayelet G; Wilson A; Belay A; Asfaw Y; Oura C; Maan S; Bachanek-Bankowska K; Mertens PP
    Transbound Emerg Dis; 2014 Apr; 61(2):185-92. PubMed ID: 23083078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the major core antigen VP7 of African horsesickness virus by a recombinant baculovirus and its use as a group-specific diagnostic reagent.
    Chuma T; Le Blois H; Sánchez-Vizcaíno JM; Diaz-Laviada M; Roy P
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():925-31. PubMed ID: 1378881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of competitive ELISA for serodiagnosis on African horsesickness virus using baculovirus expressed VP7 and monoclonal antibody.
    Kweon CH; Kwon BJ; Ko YJ; Kenichi S
    J Virol Methods; 2003 Oct; 113(1):13-8. PubMed ID: 14500122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.